0 84

Cited 8 times in

Hypoxia-specific, VEGF-expressing neural stem cell therapy for safe and effective treatment of neuropathic pain

Authors
 Hye-Lan Lee  ;  Hye Yeong Lee  ;  Yeomin Yun  ;  Jinsoo Oh  ;  Lihua Che  ;  Minhyung Lee  ;  Yoon Ha 
Citation
 JOURNAL OF CONTROLLED RELEASE, Vol.226 : 21-34, 2016 
Journal Title
 JOURNAL OF CONTROLLED RELEASE 
ISSN
 0168-3659 
Issue Date
2016
MeSH
Animals ; Cell Hypoxia ; Cell Line ; Erythropoietin/genetics ; Gene Expression Regulation ; Gene Transfer Techniques ; Male ; Mice ; Neural Stem Cells/metabolism ; Neural Stem Cells/transplantation* ; Neuralgia/genetics ; Neuralgia/pathology ; Neuralgia/physiopathology ; Neuralgia/therapy* ; Plasmids/genetics ; Promoter Regions, Genetic ; Rats ; Rats, Sprague-Dawley ; Sciatic Nerve/injuries* ; Sciatic Nerve/metabolism ; Sciatic Nerve/pathology ; Sciatic Nerve/physiopathology ; Up-Regulation* ; Vascular Endothelial Growth Factor A/genetics*
Keywords
Erythropoietin enhancer ; Neural stem cells ; Neuropathic pain ; Sciatic nerve injury ; Tumor ; Vascular endothelial growth factor
Abstract
Vascular endothelial growth factor (VEGF) is an angiogenic cytokine that stimulates the differentiation and function of vascular endothelial cells. VEGF has been implicated in improving nervous system function after injury. However, uncontrolled overexpression of VEGF increases the risk of tumor formation at the site of gene delivery. For this reason, VEGF expression needs to be strictly controlled. The goal of the present study was to understand the effects of hypoxia-induced gene expression system to control VEGF gene expression in neural stem cells (NSCs) on the regeneration of neural tissue after sciatic nerve injury. In this study, we used the erythropoietin (Epo) enhancer-SV40 promoter system (EpoSV-VEGF-NSCs) for hypoxia-specific VEGF expression. We used three types of NSCs: DsRed-NSCs as controls, SV-VEGF-NSCs as uncontrolled VEGF overexpressing NSCs, and EpoSV-VEGF-NSCs. For comparison of VEGF expression at normoxia and hypoxia, we measured the amount of VEGF secreted. VEGF expression decreased at normoxia and increased at hypoxia for EpoSV-VEGF-NSCs; thus, EpoSV-VEGF-NSCs controlled VEGF expression, dependent upon oxygenation condition. To demonstrate the therapeutic effect of EpoSV-VEGF-NSCs, we transplanted each cell line in a neuropathic pain sciatic nerve injury rat model. The transplanted EpoSV-VEGF-NSCs improved sciatic nerve functional index (SFI), mechanical allodynia, and re-myelination similar to the SV-VEGF-NSCs. Additionally, the number of blood vessels increased to a level similar to that of the SV-VEGF-NSCs. However, we did not observe tumor generation in the EpoSV-VEGF-NSC animals that were unlikely to have tumor formation in the SV-VEGF-NSCs. From our results, we determined that EpoSV-VEGF-NSCs safely regulate VEGF gene expression which is dependent upon oxygenation status. In addition, we found that they are therapeutically appropriate for treating sciatic nerve injury.
Full Text
http://www.sciencedirect.com/science/article/pii/S0168365916300438?via%3Dihub
DOI
10.1016/j.jconrel.2016.01.047
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Neurosurgery (신경외과학교실) > 1. Journal Papers
Yonsei Authors
Ha, Yoon(하윤)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/152579
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse